Plain-English translation of NCT05531773 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study following people who have recovered from COVID-19 to learn more about long-COVID — symptoms that persist or appear three months or more after the acute infection ends. Researchers across Europe, Africa, Mexico, Russia, and Asia want to understand how common these lingering symptoms are, who is most affected, and why some people experience them while others don't.
Many people report ongoing symptoms months after their COVID-19 infection clears — things like fatigue, brain fog, breathing problems, or pain — but we don't yet fully understand why this happens or how to predict who will be affected. This study aims to fill that gap by carefully tracking a large group of recovered patients to identify patterns and causes.
You likely qualify if…
You likely don't qualify if…
As a participant, you would share information about your COVID-19 experience and any symptoms you've had since recovering. The study will follow you over time to document your health status and track which symptoms persist or develop. This is an observational study, meaning researchers will collect your medical information and monitor your progress rather than giving you a specific treatment to test.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Germany
Italy
Lithuania
Mexico